| Ac Rural Health Clinic | |
|
408 E 7th St Appleton City MO 64724-1617 | |
| (660) 476-2121 | |
| Not Available |
| Full Name | Ac Rural Health Clinic |
|---|---|
| Speciality | Family Medicine |
| Location | 408 E 7th St, Appleton City, Missouri |
| Authorized Official Name and Position | Beverly A Johnson (BUSINESS OFFICE DIRECTOR) |
| Authorized Official Contact | 6604765203 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ac Rural Health Clinic 408 E 7th St Appleton City MO 64724-1617 Ph: (660) 476-2121 | Ac Rural Health Clinic 408 E 7th St Appleton City MO 64724-1617 Ph: (660) 476-2121 |
| NPI Number | 1619117256 |
|---|---|
| Provider Enumeration Date | 02/23/2009 |
| Last Update Date | 10/14/2015 |
| Medicare PECOS PAC ID | 0345153680 |
|---|---|
| Medicare Enrollment ID | O20031111000910 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619117256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Paul L Kramer |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1407848351 PECOS PAC ID: 2961476866 Enrollment ID: I20040825001171 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Jerad E Widman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083655039 PECOS PAC ID: 5496712168 Enrollment ID: I20041214000750 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Richard R Dailey |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1588675953 PECOS PAC ID: 8123090966 Enrollment ID: I20050211000886 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | John F Best |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1154373462 PECOS PAC ID: 7315986320 Enrollment ID: I20050428001064 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Anthony T Tay |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1669416046 PECOS PAC ID: 4688604911 Enrollment ID: I20050817000031 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Cynthia A Moran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104866722 PECOS PAC ID: 0941203475 Enrollment ID: I20060822000576 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Lisa R Nordberg |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114091212 PECOS PAC ID: 9638069594 Enrollment ID: I20070116000167 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Jonathan E Gray |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1578798054 PECOS PAC ID: 5597989178 Enrollment ID: I20140623000864 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Jared W Nichols |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1982018727 PECOS PAC ID: 4587954409 Enrollment ID: I20160606002094 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Jamie Lynn Ofarrell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437604592 PECOS PAC ID: 7618264920 Enrollment ID: I20160929000700 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
| Provider Name | Kendrick R Maus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992367502 PECOS PAC ID: 4284969825 Enrollment ID: I20190718001012 |
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
News Archive
A new study looking at the results of testing children for COVID-19 through a Children's National Hospital community-based testing site found that one in four patients had a positive test.
Pullman Regional Hospital and RGP Healthcare, a division of Resources Global Professionals, today jointly announced that Pullman Regional is implementing Pavisse™, a new, state-of-the-art incident management and patient safety system.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published in the Journal of Neurology also links low blood counts at a young age to ALS.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
› Verified 1 days ago
Ac Rural Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 E 7th St, Appleton City, MO 64724 Phone: 660-476-2121 Fax: 660-476-2130 | |
Ac Rural Health Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 408 E 7th St, Appleton City, MO 64724 Phone: 660-476-2121 |